Pfizer’s Vaccine Passes Kid Test, J&J’s Costly Error, and FTC Challenges Illumina

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

A Glimpse Into a Price-Controlled Future
AZ Tells Us Its Vaccine is OK. Rebuilding Trust Will Take a While
Burnout Risk Is High. People Need a Break
AZ’s Vaccine Mess, Rubius Infiltrates Solid Tumors, & Insitro’s $400M Haul